These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. In vivo liver regeneration potential of human induced pluripotent stem cells from diverse origins. Liu H; Kim Y; Sharkis S; Marchionni L; Jang YY Sci Transl Med; 2011 May; 3(82):82ra39. PubMed ID: 21562231 [TBL] [Abstract][Full Text] [Related]
29. Generation of functional human hepatic endoderm from human induced pluripotent stem cells. Sullivan GJ; Hay DC; Park IH; Fletcher J; Hannoun Z; Payne CM; Dalgetty D; Black JR; Ross JA; Samuel K; Wang G; Daley GQ; Lee JH; Church GM; Forbes SJ; Iredale JP; Wilmut I Hepatology; 2010 Jan; 51(1):329-35. PubMed ID: 19877180 [TBL] [Abstract][Full Text] [Related]
30. Human pluripotent stem cells differentiated in fully defined medium generate hematopoietic CD34- and CD34+ progenitors with distinct characteristics. Chicha L; Feki A; Boni A; Irion O; Hovatta O; Jaconi M PLoS One; 2011 Feb; 6(2):e14733. PubMed ID: 21364915 [TBL] [Abstract][Full Text] [Related]
31. Induced pluripotent stem cell-derived endothelial cells promote angiogenesis and accelerate wound closure in a murine excisional wound healing model. Clayton ZE; Tan RP; Miravet MM; Lennartsson K; Cooke JP; Bursill CA; Wise SG; Patel S Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29976773 [TBL] [Abstract][Full Text] [Related]
32. High-Content Assay Multiplexing for Vascular Toxicity Screening in Induced Pluripotent Stem Cell-Derived Endothelial Cells and Human Umbilical Vein Endothelial Cells. Iwata Y; Klaren WD; Lebakken CS; Grimm FA; Rusyn I Assay Drug Dev Technol; 2017; 15(6):267-279. PubMed ID: 28771372 [TBL] [Abstract][Full Text] [Related]
33. Activation of RARα, RARγ, or RXRα Increases Barrier Tightness in Human Induced Pluripotent Stem Cell-Derived Brain Endothelial Cells. Stebbins MJ; Lippmann ES; Faubion MG; Daneman R; Palecek SP; Shusta EV Biotechnol J; 2018 Feb; 13(2):. PubMed ID: 28960887 [TBL] [Abstract][Full Text] [Related]
34. Human induced pluripotent stem cell-derived mesenchymal stem cell seeding on calcium phosphate scaffold for bone regeneration. Tang M; Chen W; Liu J; Weir MD; Cheng L; Xu HH Tissue Eng Part A; 2014 Apr; 20(7-8):1295-305. PubMed ID: 24279868 [TBL] [Abstract][Full Text] [Related]
35. Molecular Profiling of Human Induced Pluripotent Stem Cell-Derived Cells and their Application for Drug Safety Study. Matsui T; Miyamoto N; Saito F; Shinozawa T Curr Pharm Biotechnol; 2020; 21(9):807-828. PubMed ID: 32321398 [TBL] [Abstract][Full Text] [Related]
36. Differential sensitivity to JAK inhibitory drugs by isogenic human erythroblasts and hematopoietic progenitors generated from patient-specific induced pluripotent stem cells. Ye Z; Liu CF; Lanikova L; Dowey SN; He C; Huang X; Brodsky RA; Spivak JL; Prchal JT; Cheng L Stem Cells; 2014 Jan; 32(1):269-78. PubMed ID: 24105986 [TBL] [Abstract][Full Text] [Related]
37. Induced Pluripotent Stem Cell-Derived Retinal Pigmented Epithelium: A Comparative Study Between Cell Lines and Differentiation Methods. Leach LL; Croze RH; Hu Q; Nadar VP; Clevenger TN; Pennington BO; Gamm DM; Clegg DO J Ocul Pharmacol Ther; 2016 Jun; 32(5):317-30. PubMed ID: 27182743 [TBL] [Abstract][Full Text] [Related]
39. Association of Human iPSC Gene Signatures and X Chromosome Dosage with Two Distinct Cardiac Differentiation Trajectories. D'Antonio-Chronowska A; Donovan MKR; Young Greenwald WW; Nguyen JP; Fujita K; Hashem S; Matsui H; Soncin F; Parast M; Ward MC; Coulet F; Smith EN; Adler E; D'Antonio M; Frazer KA Stem Cell Reports; 2019 Nov; 13(5):924-938. PubMed ID: 31668852 [TBL] [Abstract][Full Text] [Related]
40. Disease-specific induced pluripotent stem cells: a platform for human disease modeling and drug discovery. Jang J; Yoo JE; Lee JA; Lee DR; Kim JY; Huh YJ; Kim DS; Park CY; Hwang DY; Kim HS; Kang HC; Kim DW Exp Mol Med; 2012 Mar; 44(3):202-13. PubMed ID: 22179105 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]